Gabapentin Capsule
Product Images NDC 68788-8712
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68788-8712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Image 01)
Figure 2 (Image 02)
This text describes a pain study where participants were given different doses of Gabapentin (a medication commonly used for nerve pain) or a placebo over a 4-week period. The pain scores were measured at baseline and weekly for 7 weeks to evaluate the effectiveness of different doses of Gabapentin in reducing pain levels.*
Figure 3 (Image 03)
This text provides information on the proportion of responders (patients with at least a 50% reduction in pain score) at the endpoint of controlled post-herpetic neuralgia (PHN) studies. The results are shown for Study 1 and Study 2, comparing different treatment groups such as placebo (PBO), GBP 3600, GBP 1800, and GBP 2400. The statistical significance is indicated with p-values.*
Cockcroft And Gault Equation (Image 04)
Gabapentin Structural Formula (Image 05)
Image-09 (Image 09)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.